GORIO, ALFREDO
 Distribuzione geografica
Continente #
EU - Europa 18.653
NA - Nord America 9.778
AS - Asia 5.558
SA - Sud America 182
OC - Oceania 94
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 11
Totale 34.320
Nazione #
US - Stati Uniti d'America 9.570
GB - Regno Unito 9.074
IT - Italia 2.543
CN - Cina 2.439
DE - Germania 1.806
SE - Svezia 1.672
SG - Singapore 1.052
RU - Federazione Russa 820
TR - Turchia 619
UA - Ucraina 543
FR - Francia 542
KR - Corea 523
IE - Irlanda 447
IN - India 341
FI - Finlandia 330
EU - Europa 297
NL - Olanda 279
HK - Hong Kong 175
CA - Canada 168
GR - Grecia 104
VN - Vietnam 100
PL - Polonia 97
JP - Giappone 96
DK - Danimarca 89
CO - Colombia 88
AU - Australia 82
ID - Indonesia 79
BE - Belgio 70
ES - Italia 62
BR - Brasile 57
CH - Svizzera 43
CZ - Repubblica Ceca 23
RO - Romania 23
MX - Messico 21
CL - Cile 20
HU - Ungheria 19
IR - Iran 17
IL - Israele 16
TW - Taiwan 16
CI - Costa d'Avorio 13
AT - Austria 12
EG - Egitto 12
NZ - Nuova Zelanda 12
BS - Bahamas 10
LB - Libano 10
TH - Thailandia 10
AR - Argentina 8
MY - Malesia 8
PT - Portogallo 8
SA - Arabia Saudita 8
NO - Norvegia 7
AL - Albania 6
BG - Bulgaria 6
BH - Bahrain 6
HR - Croazia 6
JO - Giordania 6
PH - Filippine 6
UZ - Uzbekistan 6
LT - Lituania 5
SC - Seychelles 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
EE - Estonia 4
IQ - Iraq 4
LK - Sri Lanka 4
PK - Pakistan 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
KW - Kuwait 3
PE - Perù 3
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
EC - Ecuador 2
LU - Lussemburgo 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AM - Armenia 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
JM - Giamaica 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PY - Paraguay 1
RE - Reunion 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
Totale 34.609
Città #
Southend 8.656
Chandler 1.150
Milan 952
Seattle 831
Singapore 654
Princeton 566
Wilmington 524
Beijing 451
Dublin 442
Ashburn 412
Redmond 346
Mountain View 341
Ann Arbor 339
Jacksonville 339
Dearborn 329
Houston 307
Fairfield 304
Nanjing 239
Frankfurt am Main 236
Woodbridge 235
Sakarya 224
Des Moines 208
Boardman 198
Jinan 197
Hanover 191
Brooklyn 189
Bengaluru 160
Berlin 152
Hong Kong 151
Serra 150
Grafing 132
Santa Clara 129
Toronto 129
Shenyang 118
Shanghai 111
Cambridge 110
Andover 102
Rome 99
Athens 92
Bogotá 86
Phoenix 85
Nanchang 82
Medford 80
New York 72
Redwood City 71
Helsinki 70
Guangzhou 69
Hebei 67
Brussels 66
Saint Petersburg 66
Somerville 66
Tianjin 64
Changsha 60
Hangzhou 59
San Diego 59
Warsaw 56
Seoul 53
Dong Ket 52
Ningbo 52
Bühl 51
Fuzhou 51
Zhengzhou 44
Falls Church 42
Jiaxing 42
Los Angeles 41
Eitensheim 36
Bitonto 34
Haikou 34
Istanbul 33
Turin 31
Jakarta 30
Kiez 30
Taizhou 28
Verona 28
Scranton 27
Hefei 26
Kunming 26
Roxbury 26
Sydney 26
Auburn Hills 24
Lanzhou 24
Wuhan 24
Chengdu 23
Bologna 22
Quanzhou 22
Tokyo 22
London 21
Tappahannock 20
Coral Gables 19
Paris 19
Munich 18
Palermo 18
Atlanta 17
Pune 17
Nürnberg 16
Foshan 15
Columbus 14
San Jose 14
Silver Spring 14
Taiyuan 14
Totale 22.913
Nome #
A new device (Lipogems®) to obtain micronized fat tissue with a highly preserved SVF for autologous /allogenic use in Regenerative Medicine: clinical use and three years experience 1.397
Farmacologia generale e speciale per lauree sanitarie 581
Fresh and frozen Lipogems-derived micro-fractured human adipose tissue generates mesenchymal stem cells with higher differentiation potential and in vivo repair efficacy 434
Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2-/- Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM 390
New non-synthetic molecules are able to inhibit Apoptosis 345
Adipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation Capabilities 320
G protein-mediated signal transduction is affected in primary biliary cirrhosis 273
Brain adaptation to hypoxia and hyperoxia in mice 260
Women with TSC : Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis 255
Exogenous adult post mortem neural precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury 254
Third trimester human amniotic fluid cells isolation and phenothypical characterizzation 245
The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells 239
Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma : epidermal growth factor is the required growth factor 235
Up-regulation of focal adhesion kinase in non-small cell lung cancer 233
In vivo imaging of labelled neural stem cells in a mouse model of spinal cord injury 230
Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations 225
Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells 224
Acute spinal cord injury persistently reduces R/G RNA editing of AMPA receptors 221
Acrylate end-capped poly(ester-carbonate) and poly(ether-ester)s for polymer-on-multielectrode array devices : synthesis, photocuring, and biocompatibility 220
Characterization of LAM/TSC cells isolated from patient chylous 219
Adult neural precursors isolated from post mortem brain yield mostly neurons : An erythropoietin-dependent process 219
Phenotypical characterization of third trimester human amniotic fluid cells: a new reservoir of stem cells? 218
Fresh and frozen micro-fractured human adipose tissue generates mesenchymal stem cells with higher differentiation potential and in vivo repair efficacy 218
Death resistant neural progenitors yield mostly neurons: an erythropoietin-dependent process 214
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis 214
LAM/TSC cell migration to uterus in an experimental model of lymphangioleiomyomatosis. Regulation by anti-epidermal growth factor receptor antibody and rapamycin 208
Early and late posts mortem neural stem cells grow and differentiate in vitro : a novel source for cellular therapy 204
Expression of surface and intracellular specific markers by human stem cells derived from Lipostem™-treated adipose tissue 204
Farmacologia 202
Expression of the anti-apoptotic protein survivin amd altered function of IGF-1 pathway in TSC2 brain tubers 202
Development of a LAM model by using human TSC2-/- cells derived from a renal angiomyolipoma : A pharmacological evaluation 200
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells 198
Development of strategies for in vivo MRI and Optical Imaging of Neural stem cells distribution for the treatment of traumatic spinal cord injury 196
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair 195
Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1B 193
Farmacologia 191
PHENOTYPICAL CHARACTERIZATION OF THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS WITH POTENTIAL FOR THERAPY IN NEURODEGENERATIVE DISORDERS 190
Role of Prolactin Receptors in Lymphangioleiomyomatosis 190
Mechanical Activation of Adipose Tissue and Derived Mesenchymal Stem Cells : Novel Anti-Inflammatory Properties 190
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis 189
Oral manifestation in a cohort of tuberous sclerosis complex (TSC) patients 189
ERITROPOIETINA RICOMBINANTE UMANA ATTENUA LA DEGENERAZIONE SECONDARIA E PROMUOVE IL RECUPERO NEUROLOGICO NEL TRAUMA DEL MIDOLLO SPINALE SPERIMENTALE 187
PATHOGENESIS AND PHARMACOLOGY OF ISOLATED HUMAN TSC2 SMOOTH MUSCLE CELLS. NOVEL THERAPEUTIC PERSPECTIVES 185
A new class of adult neural stem cells migrate to the injured spinal cord and differentiate into cholinergic neurons 185
Third trimester human amniotic fluid cells from caesarean births; a new tool for therapy in neurodegenerative disorders 183
Isolation and characterization of a new class of adult neural precursors 183
Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury 182
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/- 181
Spinal cord injury : a comparison of neural stem cell and embryonic stem cell treatments 180
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation 180
Erythropoietin : recent developments in the treatment of spinal cord injury 180
Erythropoietin-mediated preservation of the white matter in rat spinal cord injury 178
Survivin expression in tuberous sclerosis complex cells 178
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival 178
Death resistant neural stem cell regenerate neuronal tissue and promote functional recovery after transplantation in a spinal cord injury model 176
Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury 176
Characteristics and properties of mesenchymal stem cells derived from micro-fragmented adipose tissue 176
Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping 176
Magnetic and fluorescence labelling for in vivo neural stem cell transplantation monitoring 174
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma 174
Phenotype reversion of human TSC2-/- smooth muscle cells 173
Fate of autologous dermal stem cells transplanted into the spinal cord after traumatic injury (TSCI) 172
Inhibition of apoptosis-driven regression of hair bulb 172
Molecular characterization of growth and survival of human TSC2 gene-deficient smooth muscle-like cells 172
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions 171
Characterization of human TSC2 cells derived from a TSC/LAM patient chylous effusion 170
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM 169
A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia 169
The synaptic vesicle proteins synapsin I and synaptophysin (protein P38) are concentrated both in efferent and afferent nerve endings of the skeletal muscle 169
Third trimester human amniotic fluid cells with potential for therapy in neurodegenerative disorders 168
Exogenous adult mouse post mortem neural promote functional recovery in a mouse model of Parkinson disease and differentiate in TH-positive neurons 168
Isolation and growth characterization of two types of human TSC2 gene-deficient cells 167
An epigenetic event may underlies the TSC features in TSC2 ASM cells 167
Eryrhropoietin increase neuronal differentiation increase neuronal stem cells and death resistant neural stem cells 166
Pharmacological and biochemical characterization of isolated and in vitro grown human TSC2 gene-deficient smooth muscle-like cells 165
Reversion of the phenotype of human TSC2-/- smooth muscle cells 165
Effect of different therapeutic approaches on the extracellular matrix in rodent models of spinal cord injury 165
A Novel Anti-Catagen formulation 165
Farmacologia 165
The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial-mesenchymal transition in breast cancer 165
Proliferation and invasiveness of human smooth muscle TSC2-/- : Effect of anti-EGFR and rapamycin 163
Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice 161
Erythropoietin effect on sensorimotor recovery after contusive spinal cord injury: an electrophysiological study in rats 161
Human LAM/TSC cells efficiently cause lung nodule formation and alveolar destruction. Pharmacological counteraction by modulation of mTOR activity 159
The use of poly(N-[2-hydroxypropyl]-methacrylamide) hydrogel to repair a T10 spinal cord hemisection in rat: a behavioural, electrophysiological and anatomical examination 158
ROSUVASTATIN ACTING AS A DEMETHYLATING AGENT AFFECTS PROLIFERATION OF TSC2-/meth ASM CELLS 157
Exogenous adult mouse post mortem neural promote functional recovery in a mouse model of Parkinson disease and differentiate in TH-positive neurons 157
Neuroprotection, Recovery of Function and Endogenous Neurogenesis in Traumatic Spinal Cord Injury Following Transplantation of Activated Adipose Tissue 157
Mechanisms of survival in TSC2-/- smooth muscle cells 156
Plasma amino acid concentrations throughout normal pregnancy and early stages of intrauterine growth restricted pregnancy 154
Chronic erythropoietin-mediated effects on the expression of astrocyte markers in a rat model of contusive spinal cord injury 154
LAM/TSC CELLS BEARING A TSC2 MUTATION SECRETE CHEMOKINES AND MATRIXMETHALLOPROTEINASES 154
MOTILITY AND INVASIVE PROPERTIES OF LAM/TSC CELLS FROM CHYLOUS OF A LAM/TSC PATIENT 154
Phenotype plasticity of mesenchymal stem cells from Lipostem™-derived human adipose tissue 154
Adult neural stem cell labelling protocols for in vivo MRI and optical imaging 151
Matrix methalloproteinase 2 and 7 are new targets in LAM and TSC-related disorders 149
Magnetic Resonance Imaging of Stem Cell Transplantation in Injured Mouse Spinal Cord 149
Pharmacological reversion of the phenotype of human TSC2-/- smooth muscle cells 148
Spinal cord injury and neural stem cells transplantation 147
Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis 147
Totale 20.889
Categoria #
all - tutte 89.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.944 0 0 0 0 314 421 535 250 605 491 189 139
2020/20213.790 198 213 363 101 314 193 195 131 663 202 977 240
2021/20223.266 425 133 146 109 173 153 243 166 421 397 261 639
2022/20233.839 437 412 311 516 470 786 57 219 389 27 154 61
2023/20242.291 73 179 111 140 585 153 98 174 81 109 221 367
2024/20251.775 233 518 149 598 277 0 0 0 0 0 0 0
Totale 36.457